Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
about
Recent advances in managing and understanding diabetic nephropathyStatin Therapy: Review of Safety and Potential Side EffectsLowering cholesterol in chronic kidney disease: is it safe and effective?Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis RiskEffects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with DiabetesDoctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore.Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3.Efficacy of Statin Treatment in Early-Stage Chronic Kidney DiseaseStatin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic SubjectsImprovement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspectiveClinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.Statin therapy across the lifespan: evidence in major age groups.Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.The effect of statins on renal outcomes in patients with diabetic kidney disease: A systematic review and meta-analysis.The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor.Diabetic kidney disease.Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction.Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin.Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin.Pitavastatin suppresses hyperglycaemia-induced podocyte injury via bone morphogenetic protein-7 preservation.Effects of statins on the kidneys in patients with type 2 diabetes.Chronic kidney disease: Statins in chronic kidney disease: time to move on?NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice.Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
P2860
Q26745900-8314B564-2B5A-4184-90DA-33CFDE97D642Q28072883-27FD902E-D60A-4F9D-AA9B-B09BEF8B00F4Q28083502-90378FD0-3CF0-434F-AFEE-37E3F475085CQ28554193-0F71E7CB-1D6E-4EA5-9922-FC71BA28E92EQ33840336-36B9C41D-0018-4EA0-95A1-6ADD59091FCDQ33889894-ADDA159B-37B2-4F58-A6C5-E981E78C2343Q35702827-8B057D43-9581-4E68-965E-D863404D4116Q35994934-0D4C5A06-B906-49E7-99B6-327BEE8167A6Q36138508-7CB9ABDF-7BA5-4939-8CF3-C83B7E11AF45Q36247899-5312D46B-8C53-4861-A25A-4AB82CFB4530Q36271369-CA57EF78-E33D-4593-918F-548C62E80B43Q36365884-E354BB7D-9ADB-4AF1-AAB3-5C85D55262CFQ37121221-FC795B92-1BAE-44D8-9A2B-41D0EFFAB163Q37373193-1ADD22EA-FEC0-4FA5-94D4-10F75F5B67E7Q38513740-00863ECA-226E-4ADB-8653-B8E3A9269871Q38553932-FA7CFEA0-7E46-4C5B-AA82-CADDC042FA07Q38629322-805D92C9-C396-4E58-B9E9-0924B8AB3F97Q38660929-79DCF170-26DC-4D9C-A4D7-491A012B3DCBQ38746316-F83BF121-0A61-41A4-A863-BC21EF8214F9Q39287309-0425C20F-F1CE-4BB0-ADAB-BF0D785CE7CCQ40088029-55D4F0F8-29DD-4672-BD6B-54DC599B3786Q42361500-62C95F97-04E4-4008-895D-EBF2824ACEB7Q43721013-04F7B774-C04E-4E97-80B1-DCAF11E0086DQ47900774-B8B93828-E764-45E0-8C06-E248ED8CB21EQ49855458-4E11FE20-7A4F-4DA1-936A-41F5DE2423B6Q49875790-410E44A8-D103-4E4D-B6AE-0682F6FC0499Q51193055-D15B9278-C46B-4CEA-9896-4855E1B73CF7Q51247990-8BC8402D-DAA8-4CA5-AE55-DE6F209B2F50Q51319553-44B022F1-8DD4-4E1C-B236-BAF87AB3D9ACQ53567966-1E2BA4FA-FA82-4656-AA4B-FB004285185EQ55398039-5AFEC100-828B-4972-BDC3-B2E16FF3DC66Q56984696-FD7F1B61-0311-40C3-816D-BF1A42CC9758
P2860
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Renal effects of atorvastatin ...... : a randomised clinical trial.
@en
type
label
Renal effects of atorvastatin ...... : a randomised clinical trial.
@en
prefLabel
Renal effects of atorvastatin ...... : a randomised clinical trial.
@en
P2093
P1476
Renal effects of atorvastatin ...... : a randomised clinical trial.
@en
P2093
Bruce A Molitoris
Deborah A Anzalone
Dick de Zeeuw
Donald G Vidt
Hans-Henrik Parving
Hiddo J Lambers Heerspink
James R Sowers
John T Monyak
Michael D Cressman
Valerie A Cain
P304
P356
10.1016/S2213-8587(14)70246-3
P577
2015-02-04T00:00:00Z